Role of Granulocyte Colony-stimulating Factor Therapy in Cirrhosis, 'Inside Any Deep Asking Is the Answering'
Mode of action of granulocyte-colony stimulating factor (G-CSF) as a novel therapy for stroke in a mouse model | Journal of Biomedical Science | Full Text
Colony-stimulating factors for the treatment of the hematopoietic component of the acute radiation syndrome (H-ARS): A review - ScienceDirect
Granulocyte-colony stimulating factor for stroke treatment: mechanisms of action and efficacy in preclinical studies | Experimental & Translational Stroke Medicine | Full Text
Major lessons learned from Zarxio's US launch: the start of a biosimilar revolution - GaBI Journal
NEUPOGEN® (filgrastim) Mechanism of Action
Mechanisms of stem cell mobilization. G-CSF mobilizes CD34+ cells via... | Download Scientific Diagram
Pharmacokinetic and pharmacodynamic properties of a new biosimilar fil | BS
Medicines Adverse Reactions Committee
PPT - Basis for Neulasta ® (Pegfilgrastim) Approval PowerPoint Presentation - ID:357753
ZARXIO (filgrastim-sndz) for Neutropenia and Elevation of Hematopoietic Stem Cells - Cancer Therapy Advisor
Mechanism of hematopoietic agents
Figure 3 from Hematopoietic cytokines for cardiac repair: mobilization of bone marrow cells and beyond | Semantic Scholar
Cancer Immunotherapy | SpringerLink
The five “Ws” for bone pain due to the administration of granulocyte-colony stimulating factors (G-CSFs) - ScienceDirect
Figure 1 from Neuroprotection of G-CSF in cerebral ischemia. | Semantic Scholar
Frontiers | Is There a Role for Hematopoietic Growth Factors During Sepsis? | Immunology
Granulocyte colony-stimulating factor and neutrophils—forgotten mediators of inflammatory disease | Nature Reviews Rheumatology
Filgrastim-sndz (Zarxio) - Oncology Nurse Advisor
Neuroprotection through G-CSF: recent advances and future viewpoints | SpringerLink
NEUPOGEN® (filgrastim) Mechanism of Action
Granulocyte Colony-Stimulating Factor and Its Potential Application for Skeletal Muscle Repair and Regeneration
The case for plerixafor to replace filgrastim as the optimal agent to mobilize peripheral blood donors for allogeneic hematopoietic cell transplantation - Experimental Hematology
Filgrastim - Wikipedia
